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Abstract
Recently immunoglobulins (Igs) have been found to be expressed by cells other than B lymphocytes, including various
human carcinoma cells. Sarcomas are derived from mesenchyme, and the knowledge about the occurrence of Ig production
in sarcoma cells is very limited. Here we investigated the phenomenon of immunoglobulin G (IgG) expression and its
molecular basis in 3 sarcoma cell lines. The mRNA transcripts of IgG heavy chain and kappa light chain were detected by RT-
PCR. In addition, the expression of IgG proteins was confirmed by Western blot and immunofluorescence. Immuno-electron
microscopy localized IgG to the cell membrane and rough endoplasmic reticulum. The essential enzymes required for gene
rearrangement and class switch recombination, and IgG germ-line transcripts were also identified in these sarcoma cells.
Chromatin immunoprecipitation results demonstrated histone H3 acetylation of both the recombination activating gene
and Ig heavy chain regulatory elements. Collectively, these results confirmed IgG expression in sarcoma cells, the
mechanism of which is very similar to that regulating IgG expression in B lymphocytes.
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Introduction
Until recently it was believed that immunoglobulins (Igs) were
the characteristic products of only B lymphocytes and plasma cells.
However, in the past couple of years several research groups have
reported that Igs can also be produced by non-lymphoid lineage
cells [1], including human epithelial cancer cells [2,3], human
umbilical endothelial cells [4], human and mouse neurons [5,6],
testicular spermatogenic cells and epididymal epithelial cells [7],
and lactating mammary gland epithelial cells [8]. Soft tissue
tumors are derived from mesenchyme, and both the clinical
behavior and biologic features of sarcomas (malignant soft tissue
tumors) differ markedly from those of epithelial neoplasia. Thus
far much research has been focused on Ig expression in epithelial
cancer cells and the knowledge about Ig expression in soft tissue
tumors is quite limited. Recently our group has found that IgG
protein was present in a wide variety of sarcoma tissues with IgG
protein expression correlating well with proliferation markers and
tumor grades [9]. However, whether IgG was actually produced
by these sarcoma tumor cells and the molecular basis for IgG
expression in soft tissue sarcomas have not been investigated.
The molecular mechanism of variable-diversity-joining (V[D]J)
recombination of Ig in B cells has been extensively studied in the
past decades [10,11]. Both the chromatin accessibility of Ig heavy
chain (IgH) and the recombination activating gene (RAG)
expression were found essential for the initiation of V(D)J
recombination. RAG is composed of two enzymes, RAG1 and
RAG2, and mice deficient either in RAG1 or RAG2 lost the
ability to initiate V(D)J rearrangement [12,13]. Expression of
transfected RAG 1 and 2 in fibroblasts led to rearrangement of
artificially accessible recombination substrates but did not result in
rearrangement of endogenous antigen receptor loci due to lack of
accessibility [14].
In previous studies histone acetylation and germ-line transcrip-
tion (transcription from unrearranged gene segments) correlated
both strongly with an open or an accessible chromatin structure
considered to be permissive for V(D)J recombination [15,16]. In
addition, both sense and antisense germ-line transcription were
shown to relate well with V(D)J recombination [17,18] and
treatments that activated germ-line gene transcription increased
the frequency of Ig gene rearrangement [19,20]. Several regulatory
elements in the RAG locus have been identified, including the
proximal enhancer (Ep), the distal enhancer (Ed), and the RAG
enhancer (Erag) [21,22]. The transcriptional regulatory elements of
the IgH genes include the V gene–associated proximal promoters,
the IgH gene intronic enhancer (Em), and the 39 IgH enhancer (39
EH) [23]. In B cells certain transcription factors are considered to
regulate RAG expression and control the chromatin accessibility by
binding to the regulatory elements, thus activating IgH recombi-
nation and transcription [24,25]. A putative RNA editing enzyme,
activation-induced cytidine deaminase (AID) is required for both
class switch recombination and somatic hypermutation in mouse
and human. AID-deficient mice were found unable to produce IgG,
IgA, or IgE antibodies [26,27].
In this study, we investigated IgG locus events in three sarcoma
cell lines. We used cell lines instead of primary tumor tissues as the
PLoS ONE | www.plosone.org 1 June 2011 | Volume 6 | Issue 6 | e21276use of cell lines obviated problems of contamination by other cell
types, which could arise when analyzing primary tumor tissues
given their complex in situ histology with coexisting stroma and
lymphocytes. The mRNA sequence of V(D)J recombination of
IgG heavy chain was amplified and sequenced. Western blot and
immunofluoresence (IF) confirmed the expression of IgG at the
protein level. The ultrastructural location of IgG in sarcoma tumor
cells was studied with the immuno-electron microscopy (EM)
technique. To our knowledge, this was the first time this technique
was applied to investigate IgG in cancers. The enzymes essential
Table 1. PCR primers used in this study.
Gene name RT-PCR primers Primer sequence 59-39 product size (bp)
CD19 The same sense primer TACTATGGCACTGGCTGCTG 218
External antisense primer TGCTCGGGTTTCCATAAGAC
Internal antisense primer CACGTTCCCGTACTGGTTCT
RAG1 External sense primer TGGATCTTTACCTGAAGATG 327
External antisense primer CTTGGCTTTCCAGAGAGTCC
Internal sense primer CACAGCGTTTTGCTGAGCTC
Internal antisense primer AGCTTGCCTGAGGGTTCATG
RAG2 External sense primer TGGAAGCAACATGGGAAATG 193
External antisense primer CATCATCTTCATTATAGGTGTC
Internal sense primer TTCTTGGCATACCAGGAGAC
Internal antisense primer CTATTTGCTTCTGCACTG
AID External sense primer GAAGAGGCGTGACAGTGCT 294
External antisense primer CGAAATGCGTCTCGTAAGT
Internal sense primer CCTTTTCACTGGACTTTGG
Internal antisense primer TGATGGCTATTTGCACCCC
IGHG1 External sense primer ACGGCGTGGAGGTGCATAATG 201
C region External antisense primer CGGGAGGCGTGGTCTTGTAGTT
Internal sense primer GACTGGCTGAATGGCAAGGAG
Internal antisense primer GGCGATGTCGCTGGGATAGAA
Ig k Sense primer TGAGCAAAGCAGACTACGAGA 231
C region Antisense primer GGGGTGAGGTGAAAGATGAG
IGHG1 VH1-leader CCATGGACTGGACCTGGA 300-330
V region VH3-leader CCATGGAGTTTGGGCTGAGC
VH5-leader ATGGGGTCAACCGCCATCCT
CH1 ACACCGTCACCGGTTCGG
VH1-FR1 CCTCAGTGAAGGTCTCCTGCAAGG
VH3-FR1 GGTCCCTGAGACTCTCCTGTGCA
VH5-FR1 GAAAAAGCCCGGGGAGTCTCTGAA
LJH TGAGGAGACGGTGACC
Ic-Cc External sense primer GGGCTTCCAAGCCAACAGGGCAGGACA 311
External antisense primer CAAGCTGCTGGAGGGCACGGT
Internal sense primer GGTGAACCGAGGGGCTTGT
Internal antisense primer CGCTGCTGAGGGAGTAGAGT
b-actin Sense primer TAAAGACCTCTATGCCAACACAG 218
Antisense primer CACGATGGAGGGGCCGGACTCATC
ChIP PCR primers
Erag Sense primer GCACTGCAAATGGCCTGTGAAC 197
Antisense primer TAGAGACCAGAGGGCTTAACATT
Em Sense primer CAGCCCTTGTTAATGGACTT 250
Antisense primer GGAAAGTTAAATGGGAGTGACC
39Ca HS4 Sense primer TCCAGTCTGAAAAACAAGACC 188
Antisense primer ACCTCCCCCAATGCAAATC
39Ca HS3 Sense primer AGGTCTCGACTTAGCACTG 228
Antisense primer GGCATGTTTCTCAGAACAGC
doi:10.1371/journal.pone.0021276.t001
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detected in these cell lines. Chromatin immunoprecipitation
(ChIP) results showed histone H3 acetylation of both Erag and
IgH regulatory elements. These results indicate that the active IgH
chromatin status and RAG expression mediate Ig expression in
sarcoma cells, the mechanism of which shares many similarities
with that controlling Ig expression in B lymphocytes.
Materials and Methods
Ethics statement
This study was approved by the ethics committee at Shantou
University, China. Written informed consent was obtained from
all participants involved in our study.
Cell culture
The human Ewing’s sarcoma cell line A673, osteosarcoma cell
line U-2 OS, fibrosarcoma HT1080 and Burkitt lymphoma cell
line Raji were obtained from the American Type Culture
Collection (ATCC). A673 was cultured in Dulbecco’s Modified
Eagle’s Medium (DMEM, Invitrogen, Carlsbad, CA) with 10%
FBS (Hyclone/Thermo Fisher Scientific Inc., Waltham, MA). U-2
OS, HT1080 and Raji were cultured in Roswell Park Memorial
Institute (RPMI) 1640 medium (Invitrogen, Carlsbad, CA) with
10% FBS at 37uC in a humidified atmosphere with 5% CO2.
Isolation of Peripheral Blood Mononuclear Cells (PBMC)
Peripheral blood was obtained from one healthy donor.
Mononuclear cells were isolated from 3 ml of peripheral blood
using two-step discontinuous Ficoll-Hypaque gradients (Solarbio,
Beijing, China). The white gradient layer containing mononuclear
cells was collected and washed with 0.01 M PBS, and the isolated
mononuclear cells were used immediately for total RNA extraction.
RNA extraction and RT-PCR
Total RNA was extracted from the cells using Trizol reagent
(Invitrogen, Carlsbad, CA) and treated with RNase Free DNase
(Invitrogen) to remove genomic DNA. Reverse transcription of total
RNA was performed using the Superscript
TM III First Strand
Synthesis System (Invitrogen, Carlsbad, CA) following the manufac-
turer’s instructions. For the negative control, the reverse transcriptase
was omitted in the reaction mixture. Conventional, nested or semi-
nested PCR was performed and the primers used in this study are
listed in Table 1. The identities of the PCR products were confirmed
by DNA sequencing. For IgG1 heavychain (IGHG1) variableregion,
VH1, 3, 5 leader and CH1 primerswere used in the firstround PCR.
VH1, 3, 5-FR1 and LJH primers were used in the second round
PCR.ThePCRproductswereclonedintoapGM-Tvector(Tiangen
Biotech, Beijing, China) and sequenced. The V(D)J recombination
sequences were aligned with Ig germ-line variable sequences in the
Genebank. Barrier tips (Axygen, Union, CA) were used in the whole
procedure to exclude cross contamination.
SDS-PAGE and Western blot
Cell lysates were prepared using cell lysis buffer (Cell Signaling
Technology) or RIPA buffer. About 40 mg total cellular protein
was separated on 4% to 10% SDS-PAGE gel (IgG under
nonreducing conditions and other proteins under reducing
conditions). Standard human IgG (0.05 mg/well, Sigma, St. Louis,
MO) was used as a positive control and fetal bovine serum (FBS,
10 ml/well, Hyclone) was used as a negative control. The
separated proteins were transferred to a polyvinylidene difluoride
membrane. Monoclonal mouse anti-human IgG antibody (c chain
specific, Sigma), rabbit anti-human RAG1 (K-20), RAG2 (D-20)
or mouse anti-human GAPDH (0411) was used as the primary
antibody. RAG1, RAG2 and GAPDH antibodies were purchased
from Santa Cruz Biotechnology. After incubation with appropri-
ate secondary antibodies (goat anti-mouse IgG-HRP or goat anti-
rabbit IgG-HRP, Santa Cruz Biotechnology), the immunoblots
were developed using Super ECL Plus Detection Reagent
(Applygen Technologies, Beijing) and exposed to X-ray film
according to the manufacturer’s protocol.
Immunofluorescence
Cells were grown on slides and fixed in 4% paraformaldehyde for
15 min at room temperature. The slides were incubated with 0.5%
Triton X-100 for 10 min, and blocked for 1 hourin PBS containing
4% bovine serum albumin (BSA). The primary antibody,
monoclonal mouse anti-human IgG antibody (c chain specific,
Sigma, St. Louis, MO) or rabbit anti-human k chain antibody
(Zymed Laboratories, South San Francisco, CA) was added and
incubated overnight at 4uC. Isotype controls were performed using
normal mouse or rabbit IgG at the same concentration as the
primary antibodies. The slides were then washed and incubated
with goat anti-mouse IgG-FITC (green reaction product) or goat
anti-rabbit IgG-TRITC (red reaction product) for 30 min at room
temperature. After a final wash, slides were mounted withmounting
media with DAPI (Vector Laboratories, Burlingame, CA) and
examined under a fluorescence microscope (Carl Zeiss).
Immuno-electron microscopy
For immuno-EM, the sarcoma cells were fixed in 2%
paraformaldehyde with 0.2% glutaraldehyde in 0.1 M PBS (pH
7.4) at 4uC overnight. After dehydration in graded ethanol on ice,
the samples were polymerized in LR White resin. A glass knife was
used to cut semi-thin sections (1–2 mm), which were stained with
toluidine blue, and examined to select areas of interest. Finally,
ultra-thin (70–90 nm) sections, cut with a diamond knife, were
collected on 200-mesh nickel grids. Dried grids were blocked with
5% BSA in PBST (0.1% Tween 20 in 0.1 M PBS) for 1 hour,
Figure 1. Gene transcripts expression of IGHG1, kappa light
chain, RAG1/2, AID and Ic-Cc in sarcoma cell lines. b-actin was
used as an internal control. PBMC was used as a positive control. DNase
treated RNA without adding reverse transcriptase was used as a
negative control (NC).
doi:10.1371/journal.pone.0021276.g001
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The grids were then washed in 0.1 M PBST washing buffer, and
then incubated with the secondary antibody for 1 hour. The grids
were thoroughly washed in washing buffer and then in distilled
water. After air drying, the sections were stained with 5% uranyl
acetate, and viewed using a JEOL JEM-1400 transmission electron
microscope (TEM) operating at 80 kV. The primary antibody was
mouse anti-human IgG antibody (c chain specific, Sigma) or
rabbit anti-human IgG antibody (c chain specific, Dako
Carpinteria, CA, USA). The secondary antibody was 10 nm gold
conjugated goat anti-mouse IgG (Sigma, St. Louis, MO, USA) or
20 nm gold conjugated goat anti-rabbit IgG (Abcam, USA).
Chromatin crosslinking and immunoprecipitation
ChIP was performed as described previously [22]. The rabbit
anti-acetyl-histone H3 (06-599, Upstate Biotechnology) was used
and normal rabbit IgG (sc-2027, Santa Cruz) was used as a
negative control. Immunoprecipitated DNA sequences were
analyzed by PCR and the primers are listed in Table 1.
Results
Both IgG heavy chain and kappa light chain were
expressed in sarcoma cell lines
To exclude contamination with B lymphocytes in the sarcoma cell
lines, RT-PCR with CD19 primers was performed. CD19 could not
be amplified from either Ewing’s sarcoma cell line A673, osteosarcoma
cell line U-2 OS or fibrosarcoma HT1080 by two rounds of PCR.
However it could be detected easily in PBMC (Figure 1). The mRNA
of the constant region segments of both IGHG1 and kappa light chains
were detected in these sarcoma cell lines (Figure 1).
IgG proteins were found in all of the three sarcoma cell lines
using Western blot assay (Figure 2). The monoclonal mouse anti-
human IgG reacted only with human IgG but not with the bovine
IgG present in the FBS (Figure 2). This result indicated that IgG
proteins were synthesized by the sarcoma cells rather than
obtained from the culture medium.
To localize IgG heavy chain and kappa light chain in the
sarcoma cells, we performed IF. The result showed that both IgG
heavy chain and kappa light chain were expressed in the sarcoma
cell lines and that they were located predominantly in the
cytoplasm and to a lesser extent on the cell membrane (Figure 3).
The V(D)J recombination pattern expressed by sarcoma
cell lines
Following RT-PCR, the V(D)J recombination sequences were
cloned and sequenced. Three clones from each sarcoma cellline were
randomly selected for sequencing. The homology of sarcoma derived
Figure 3. Immunofluorescence showing IgG expression in sarcoma cell lines. A, normal mouse IgG was used instead of the primary
antibody (negative control). B to D, the primary antibody was monoclonal mouse anti-human IgG antibody (c chain specific). A to D, the secondary
antibody was goat anti-mouse IgG-FITC. E, normal rabbit IgG was used instead of primary antibody (negative control). F to H, the primary antibody
was rabbit anti-human k chain antibody. E to H, the secondary antibody was goat anti-rabbit IgG-TRITC.
doi:10.1371/journal.pone.0021276.g003
Figure 2. Western blot showing IgG, RAG1 and RAG2
expression in sarcoma cells. A, IgG protein was expressed in
sarcoma cells. FBS was used as a negative control and human IgG (hIgG)
was used as a positive control. B, RAG1 and RAG2 proteins were both
expressed in sarcoma cells. Raji cell was used a positive control. GAPDH
was used as an internal control.
doi:10.1371/journal.pone.0021276.g002
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shown in Table 2. The sequences from all the 9 clones showed
potentially functional V region gene recombination because there
were no mutations that introduced stop codons into the V region. For
the variable region, VH5-51 was detected most frequently and could
be amplified from A673, U-2 OS and HT1080 cells. The frequency
of VH5-51 was 4/9 clones. VH3-23 could also be amplified from
A673 and U-2 OS cells. For the diversity region, DH3 was used most
frequently and seen in 5/9 clones. For the joining region, JH4u s a g e
was most frequent and seen in 5/9 clones (Table 2).
The ultrastructural localization of IgG in sarcoma cell lines
To localize IgG in the subcelluar component of sarcoma cells,
immuno-EM was performed and the result indicated that IgG was
localized to the cell membrane and rough endoplasmic reticulum
(RER, Figure 4). RER is the place where proteins are usually
synthesized in the cytoplasm. This result provided additional
evidence showing that IgG was synthesized in sarcoma cell lines.
The RAG1, RAG2 and AID enzymes were expressed in
sarcoma cell lines
To explore the mechanism of IgG production in sarcoma cells,
we investigated the expression of several enzymes, including
RAG1, RAG2 and AID. RT-PCR results showed the expression
of RAG1, RAG2 and AID in cells of A673, U-2 OS and
HT1080 cell lines (Figure 1). The proteins of RAG1 and RAG2
were also detected by Western blot (Figure 2). Germ-line
transcription was used as an indicator of chromatin accessibility,
and Ic-Cc germ-line transcript was detected in these sarcoma
cell lines (Figure 1).
The histone H3 of RAG and IgH regulatory elements were
acetylated
Acetylation of histones H3 and H4 is well known to mark
transcriptionally active chromatin. To confirm that the chromatin
of RAG and IgH gene was in an open or accessible state, ChIP
assay was performed and the result showed that both Erag and
IgH (Em,3 9Ca HS4 and 39Ca HS3) contained acetylated histone
H3 in the sarcoma cell lines (Figure 5).
Discussion
In this study we investigated IgG locus events in the
mesenchyme derived sarcoma cell lines A673, U-2 OS and
HT1080. Both the IgG mRNA segments and proteins were
expressed in these cells. V(D)J recombination segments were
obtained by RT-PCR and sequenced. Immuno-EM localized IgG
specifically to the cell membrane and RER at the ultrastructural
level. Ic-Cc germ-line transcript was also detected in these
sarcoma cell lines. ChIP assay indicated that histone H3 of
RAG and IgH regulatory elements were acetylated. These results
show that, like epithelial cancer cells [1], the sarcoma cells also
have the essential elements for V(D)J recombination and IgG
expression. Therefore, IgG production appears to be a common
feature of both epithelium and mesenchyme derived tumor cells.
In our RT-PCR experiments, we used barrier tips during the
whole procedure to exclude cross contamination. In addition, we
always used DNase treated RNA without adding reverse
transcriptase as templates of PCR for the negative controls. This
kind of negative controls excluded the possibility of genomic DNA
contamination and contamination by reagents. Under these rigid
Figure 4. Immuno-EM showing IgG distribution in ultra-thin sections of A673 cells. A, the localization of IgG in A673 cells using 10 nm
gold particles. IgG was localized to the membrane of A673 cells. A higher magnification of the boxed area is shown in the insert. Scale bar, 500 nm.
Insert scale bar, 250 nm. N, nucleus. B, the localization of IgG in A673 cells using 20 nm gold particles. IgG was localized to the rough endoplasmic
reticulum (RER) in the cytoplasm of A673 cells. Scale bar, 500 nm.
doi:10.1371/journal.pone.0021276.g004
Figure 5. Histone H3 acetylation of the regulatory elements of
RAG and IgH gene in A673 cells. HS3, 39Ca HS3. HS4, 39Ca HS4. The
chromatin precipitated with normal rabbit IgG was used as a negative
control. U-2 OS and HT 1080 cells showed similar results (data not
shown).
doi:10.1371/journal.pone.0021276.g005
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sequences from the sarcoma cell lines. For the variable region,
VH5-51 was found in each of the three sarcoma cell lines we used.
Interestingly, previous studies have shown that VH5-51 was also
expressed in cells of breast cancer, lung cancer, colon cancer and
oral cancer [28,29]. VH3-23 was found in A673, U-2 OS cells and
it has also been found in breast cancer and oral cancer cells
[28,29]. VH3-74 was found in HT1080 cells and breast cancer
cells [28]. VH3-33 was expressed in both A673 and oral cancer
cells [29]. For the DH and JH regions, DH3 and JH4 were used
most frequently in the sarcoma cells, which is consistent with the
findings in epithelial cancer cells [29]. A recent study on sporadic
histiocytic/dendritic cell sarcoma tissues has shown Ig gene
rearrangements in sarcoma cells [30]. VH3-23 and VH5-51 were
both amplified and most of the JH gene usages were selected from
the JH4 family (5/9 cases). Collectively, these results indicate that
the V(D)J recombination patterns used by sarcoma cells are similar
to those of epithelial cancer cells. Especially VH5-51, which was
frequently detected in both sarcoma cells and epithelial cancer
cells, might be associated with yet unidentified functions in tumors
of epithelial and mesenchymal origin.
In B cells, the RAG gene has several regulatory elements to
activate its transcription, among which Erag is the most important
one. Deletion of this sequence from the mouse germline resulted in
a 5-fold to 10-fold decrease in RAG expression and a partial block
at the pro-B to pre-B transition [21]. For the IgH gene, Em was a
strong cis-regulatory element for activating V(D)J recombination
in B lymphocytes. Deletion of Em caused a significant inhibition of
both DH to JH and VH to DJH rearrangements [31,32,33]. The 39
IgH regulatory region (39Ca HS4 and 39Ca HS3) functions to
control isotype switching and to influence expression of rearranged
VHDJH exons assembled upstream at the JH region [34,35]. In our
study, we have chosen to study the chromatin acetylation status of
the most important regulatory elements of RAG and IgH gene,
while that of other less important regulatory elements has not been
studied.
In the present study we have demonstrated IgG locus events in
three sarcoma cell lines, but there are still several questions
regarding V(D)J recombination in tumors that need to be
answered. For example, in B cells DH to JH recombination occurs
in 2 alleles and VH to DJH recombination occurs only in 1 allele
because of allelic exclusion [11]. Whether allelic exclusion also
takes place in tumor cells is currently unknown. In B cells several
transcription factors, including E2A, EBF, Ikaros, and Pax5
activate RAG expression and V(D)J recombination [23,24].
Whether these transcription factors are also present in tumor cells
has not yet been explored. These questions provide directions for
future research. Finding the answers will enrich our knowledge of
Ig expression in non-lymphoid lineage cells. Our previous study
has shown that IgG expression correlated well with the
proliferation markers and tumor grades in sarcoma tissues [9].
The exact role of IgG in tumor progression warrants further
investigation.
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